Bill Text: HI SCR132 | 2011 | Regular Session | Amended
Bill Title: Atopic Diseases; Climatotherapy Tourism; Exploratory Study (SD1)
Spectrum: Strong Partisan Bill (Democrat 15-1)
Status: (Engrossed - Dead) 2011-04-14 - (H) Referred to HLT/TOU, HED, FIN, referral sheet 57 [SCR132 Detail]
Download: Hawaii-2011-SCR132-Amended.html
|
THE SENATE |
S.C.R. NO. |
132 |
|
TWENTY-SIXTH LEGISLATURE, 2011 |
S.D. 1 |
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
SENATE CONCURRENT
RESOLUTION
REQUESTING AN EXPLORATORY STUDY ON HAWAII'S SUITABILITY AS A CLIMATOTHERAPY TOURISM DESTINATION FOR ATOPIC DISEASE PATIENTS FROM EAST ASIA.
WHEREAS, there continues to be a worldwide increase in the prevalence of atopic diseases, including asthma, allergic rhinoconjunctivitis, and atopic eczema and dermatitis; and
WHEREAS, the prevalence of atopic diseases has been shown to be affected by the level of urbanization, industrialization, and geographical latitude; and
WHEREAS, symptoms of atopic dermatitis manifest as an irritated skin condition ranging from mild chronic itching to severe itching with cracking, swelling, crusting, and scaling of the skin; and
WHEREAS, atopic dermatitis occurs most frequently in children and adolescents, and as a chronic disease it can appear for the first time or reappear in adulthood; and
WHEREAS, symptoms can be aggravated by environmental irritants, including exposure to chemicals, synthetic materials, cold or dry weather, air pollutants, air-borne allergens, as well as stress; and
WHEREAS, Japanese physicians have identified Hawaii, with its clean air, light humidity, and remote location, as a healing environment for relief from some of the symptoms associated with atopic diseases; and
WHEREAS, Hawaii is already a preferred vacation destination for many families in East Asia; and
WHEREAS, the global market for the atopic dermatitis therapeutics market is expected to grow to $942,000,000 by 2017; and
WHEREAS, Hawaii is uniquely situated to capture a portion of the revenue derived from this therapeutic market in the form of climatotherapy tourism; now, therefore,
BE IT RESOLVED by the Senate of the Twenty-sixth Legislature of the State of Hawaii, Regular Session of 2011, the House of Representatives concurring, that the University of Hawaii at Manoa, in partnership with the Hawaii Tourism Authority, is requested to undertake an exploratory study evaluating the suitability of Hawaii's facilities and environmental factors with respect to the promotion of the State as a climatotherapy tourism destination for atopic disease patients, particularly from East Asia; and
BE IT FURTHER RESOLVED that the exploratory study include the following:
(1) An assessment of the potential economic benefits that may be derived from the promotion of Hawaii as a climatotherapy tourism destination for patients suffering from atopic diseases;
(2) A determination of the size of the East Asian market for climatotherapy services for atopic disease patients;
(3) An examination of the cultural factors and needs associated with the establishment of a climatotherapy tourism market in Hawaii for atopic disease patients;
(4) Identification of enterprises and operators in the State that can provide the climatotherapy services required by patients suffering from atopic disease; and
(5) An evaluation of the potential business and health industry needs that may arise from the promotion of Hawaii as a climatotherapy destination for patients suffering from atopic disease; and
BE IT FURTHER RESOLVED that the University of Hawaii at Manoa and the Hawaii Tourism Authority are requested to submit their written findings and policy recommendations to the Legislature no later than twenty days prior to the convening of the Regular Session of 2012; and
BE IT FURTHER RESOLVED that certified copies of this Concurrent Resolution be transmitted to the Chancellor of the University of Hawaii at Manoa and Chairperson of the Hawaii Tourism Authority Board of Directors.
Atopic Diseases; Climatotherapy Tourism; Exploratory Study (SD1)
